# Circulating Tumor

Top podkast episoder
Oppdatert:

Thriving through a stage 4 breast cancer diagnosis at the age of 38 - New blood test, Circulating tumor DNA

Melissa Colonna born and raised in Chicago, IL but has lived in Denver, Colorado area for the last 8 years. She lives with her husband, Don, their two young boys, and two high energy dogs. Nathan is 4 and Nolan is 2 years old. Melissa currently works in the aviation industry in Quality Assurance. S…

Wise Divine Women presents Dr. John Oertle of Envita Medical Centers explains why this discovery could reshape follow-up care for survivors

In this episode of the Wise Divine Women podcast, Dana Irvine and Dr. John Oertle discuss the latest advancements in breast cancer research, focusing on recurrence rates, the role of circulating tumor cells, and the importance of optimizing the immune system. Dr John's main goal is to enlighten Am…

196. The Power of Circulating Tumor DNA (CT DNA) and Genetic Testing in Breast Cancer Treatment Decisions with Natera’s Janie Fielder.

Love the podcast? Send us a text! In this episode of Breast Cancer Conversations, Laura Carfang, founder of SurvivingBreastCancer.org, speaks with Janie Fielder a medical science liaison at Natera. The conversation centers around Signatera as well as genetic testing and the tools available for brea…

Episode 221: Dr Osama Khan - Bridging Diagnostics And Precision Medicine At Natera

Today my guest is Dr Osama Khan from Natera What we discuss with Dr Khan : His journey into pathology The importance of mentorship in pathology Pathology at the intersection of diagnostics and precision medicine The collaborative nature of pathology Transitioning from academia to industry …

42: Catch Cancer as Early As Stage ZERO – The Most Advanced Early Detection Test You’ve Never Heard Of with Sumit Rai

In this episode of Modern Thyroid Wellness, host McCall McPherson sits down with Sumit Rai, founder of Cancer Check Labs, to discuss a groundbreaking approach to early cancer detection. Motivated by his sister’s battle with cancer, Sumit shares how their advanced blood test identifies circulating t…

Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr John Strickler, including the following topics: Defining molecular residual disease (MRD); tumor-informed and tumor-naïve methods for assessing (0:00) GALAXY and BESPOKE CRC studies of a tumor-informed MRD assay to identify patients …

Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm

Featuring an interview with Dr Shannon N Westin, including the following topics: Biomarker testing and utility in ovarian cancer (OC) (0:00) Selection of a PARP inhibitor for the treatment of OC (9:18) Addition of immunotherapy to up-front treatment of OC (15:50) Utility of minimal residual d…

“Ironing out” Tet2-mutant HSPCs; A CAR-T “license to kill” in T cell leukemia/lymphoma; insights on cHL genetics, through the lens of ctDNA

In this week's episode, we'll learn about how TET2 is often mutated in myeloid malignancies and clonal hematopoiesis. In new work, expansion of Tet2-mutant HSPCs was dependent on Ncoa4, the cargo receptor mediating ferritinophagy. We’ll iron out the implications. After that: a double-oh-seven licen…

Advances in “Liquid Biopsy” and Circulating Tumor DNA

In this episode, Dr. Peter Dziegielewski explores the concept of liquid biopsy—an innovative approach to cancer diagnosis. Learn about its applications in tracking treatment efficacy, monitoring minimal residual disease, and the evolving role of circulating tumor DNA. This episode is essential for…